Medicare Enrolled

Dr. Stanley Whitney, M.D.

Neurology · Tallahassee, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2868 MAHAN DR, Tallahassee, FL 32308
8509427177
In practice since 2006 (19 years)
NPI: 1942306824 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Whitney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Whitney? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Whitney

Dr. Stanley Whitney is a neurology in Tallahassee, FL, with 19 years in practice. Based on federal Medicare data, Dr. Whitney performed 1,060 Medicare services across 758 unique beneficiaries.

Between the years covered by Open Payments, Dr. Whitney received a total of $15,577 from 73 pharmaceutical and/or device companies across 858 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Whitney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 30% volume in FL$ $15,577 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,060
Medicare services
Top 30% in FL for neurology
758
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~56 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)466$60$120
Needle measurement of electrical activity in arm or leg muscles, complete study147$73$140
Hospital follow-up visit, high complexity104$92$170
New patient office visit (45-59 min)85$116$250
Nerve conduction, 7-8 studies79$131$300
Initial hospital admission, high complexity52$125$300
Office visit, established patient (10-19 min)50$42$80
EEG, extended monitoring47$330$570
Nerve conduction, 13 or more studies15$206$500
Office visit, established patient (30-39 min)15$81$167
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,577
Total received (2018-2024)
Avg $2,225/year across 7 years
Top 20% in FL for neurology
73
Companies
858
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,541 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,209
2023
$2,446
2022
$2,816
2021
$2,598
2020
$1,767
2019
$2,005
2018
$1,736

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$1,087
Novartis Pharmaceuticals Corporation
$986
Alexion Pharmaceuticals, Inc.
$837
Biogen, Inc.
$722
UCB, Inc.
$716
Teva Pharmaceuticals USA, Inc.
$713
Amgen Inc.
$710
Eisai Inc.
$659
GENZYME CORPORATION
$547
ABBVIE INC.
$540
EMD Serono, Inc.
$475
Lundbeck LLC
$457
Supernus Pharmaceuticals, Inc.
$447
PFIZER INC.
$425
Adamas Pharmaceuticals, Inc.
$412
AbbVie Inc.
$386
Greenwich Biosciences, Inc.
$363
Genentech USA, Inc.
$362
SK Life Science, Inc.
$344
EISAI INC.
$318
ACADIA Pharmaceuticals Inc
$283
MITSUBISHI TANABE PHARMA AMERICA, INC.
$258
JAZZ PHARMACEUTICALS INC.
$243
Sunovion Pharmaceuticals Inc.
$180
Neurocrine Biosciences, Inc.
$165
Neurelis, Inc.
$163
Kyowa Kirin, Inc.
$156
Biohaven Pharmaceuticals, Inc.
$148
Biohaven Pharmaceutical Holding Company Ltd.
$137
Horizon Therapeutics plc
$136
Octapharma USA, Inc.
$133
Otsuka America Pharmaceutical, Inc.
$132
Mitsubishi Tanabe Pharma America, Inc.
$120
GE HEALTHCARE
$117
ARGENX US, INC.
$115
Abbott Laboratories
$108
CSL Behring
$96
Jazz Pharmaceuticals Inc.
$78
Avanir Pharmaceuticals, Inc.
$77
Sumitomo Pharma America, Inc.
$72
Boston Scientific Corporation
$70
Grifols USA, LLC
$65
IMPEL PHARMACEUTICALS INC.
$64
Mallinckrodt Hospital Products Inc.
$62
Impax Laboratories, Inc.
$61
Upsher-Smith Laboratories LLC
$52
Acorda Therapeutics, Inc
$50
Janssen Pharmaceuticals, Inc
$48
Celgene Corporation
$44
Takeda Pharmaceuticals U.S.A., Inc.
$43
Mallinckrodt LLC
$42
Catalyst Pharmaceuticals, Inc.
$41
GE HealthCare
$40
Medtronic, Inc.
$38
Amneal Pharmaceuticals LLC
$34
ASSERTIO THERAPEUTICS, Inc.
$34
CATALYST PHARMACEUTICALS, INC.
$33
Avion Pharmaceuticals
$33
Scilex Pharmaceuticals Inc.
$31
US WorldMeds, LLC
$30
LivaNova USA, Inc.
$30
Allergan, Inc.
$26
Merck Sharp & Dohme Corporation
$24
SCILEX PHARMACEUTICALS INC.
$21
Mallinckrodt Enterprises LLC
$18
TG THERAPEUTICS, INC.
$18
Promius Pharma LLC
$18
AbbVie, Inc.
$17
Merck Sharp & Dohme LLC
$16
BOSTON SCIENTIFIC CORPORATION
$14
ASSERTIO THERAPEUTICS, INC.
$14
Zyla Life Sciences, Inc.
$12
PORTOLA PHARMACEUTICALS, LLC
$11
Top 3 companies account for 18.7% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BELSOMRA · BOTOX · BRIUMVI · Briviact · COPAXONE · Cambia · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · LINQ II · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONGENTYS · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SenSight · Skyclarys · Soliris · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vercise · ZEPOSIA · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,469 per 100 Medicare services performed
Looking for a neurology in Tallahassee?
Compare neurologys in the Tallahassee area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
20
Per 100K population
6.8
County median income
$65,074
Nearest hospital
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Whitney is a clinical cardiology specialist, with above-average Medicare volume (top 30% in FL), and high industry engagement (low-engagement, top 20%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Whitney experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Whitney performed 466 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Whitney receive payments from pharmaceutical companies?
Yes. Dr. Whitney received a total of $15,577 from 73 companies across 858 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Whitney's costs compare to other neurologys in Tallahassee?
Dr. Whitney's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Whitney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →